Sony | GenomeWeb

Sony

Korea Institute of Science and Technology has been awarded

Applied Biosystems (Life Technologies) has been awarded US Patent No. 8,637,658, "Non-fluorescent quencher compounds and biomolecular assays."

NEW YORK (GenomeWeb News) – Sony Corporation and M3 plan to establish a new company in Japan by the end of February 2014 in which Illumina will be a minority investor. Additionally, the three firms will collaborate to launch a new genome information platform in Japan, the firms said today.

Bio-Rad has been awarded US Patent No. 8,633,015, "Flow-based thermocycling system with thermoelectric cooler."

Sony of Tokyo has received US Patent No.

Micronics (Sony) has been awarded US Patent No. 8,431,389, "Portable high-gain fluorescence detection system."
Frederick Battrell and Troy Daiber are named as inventors.

Saint Louis University has received US Patent No. 8,431,388, "Three-component biosensors for detecting macromolecules and other analytes." According to the patent, the molecular biosensor generally consists of two epitope-binding agents and an oligonucleotide construct.

Roche Molecular Systems has been awarded US Patent No. 8,329,884, "Reagents and methods for detecting Neisseria gonorrhoeae."
Diane Kawa, Shi-Da Lu, and Peter Dailey are named as inventors.

Aushon Biosystems of Billerica, Mass., has received US Patent No. 8,246,760, "Continual flow pin washer." The patent describes a multi-chambered deposition pin wash station that includes a lower chamber and an upper drain basin connected by wash tubes.

Samsung Electronics has been awarded US Patent No.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.